What does BIOQUBE VENTURES do?

BIOQUBE VENTURES is an asset manager in Hasselt. Public Limited, started on 4 December 2019, 2 establishments.

What is the address of BIOQUBE VENTURES?

The registered office of BIOQUBE VENTURES is located at Uilstraat 30, 3500 Hasselt.

Is BIOQUBE VENTURES still active?

Yes. According to the CBE (29 October 2026) BIOQUBE VENTURES is active, legal situation “Normale toestand”, started on 4 December 2019.

Is BIOQUBE VENTURES registered on Peppol?

Yes, BIOQUBE VENTURES is registered on the Peppol network with ID 0208:0738714089.

What is the enterprise number of BIOQUBE VENTURES?

The enterprise number of BIOQUBE VENTURES is BE0738714089.

When was BIOQUBE VENTURES founded?

BIOQUBE VENTURES was founded on 4 December 2019.

Is BIOQUBE VENTURES a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 4 December 2019; 4 annual accounts filed, latest fiscal year 2025; 3 directors known from the annual account; 2 establishments in the CBE.

How much profit did BIOQUBE VENTURES make in 2025?

BIOQUBE VENTURES recorded a loss after taxes of € 31,934 in financial year 2025.

What is the revenue of BIOQUBE VENTURES?

As a small company, BIOQUBE VENTURES is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € -26,324.

How many employees does BIOQUBE VENTURES have?

According to the 2025 annual accounts, BIOQUBE VENTURES has 0 full-time equivalents (FTE).

BIOQUBE VENTURES (Public Limited) - Hasselt

Q: Who are the directors of BIOQUBE VENTURES?

According to the 2025 annual accounts, the directors of BIOQUBE VENTURES are: DEBORA DUMONT MANAGEMENT COMPANY CommV, NICO VANDERVELPEN MANAGEMENT COMPANY BV, R&S Consulting BV.

Dossier BIOQUBE VENTURES, printed on 29 October 2026 from databakkes.be/en/0738714089/bioqube-ventures. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Two loss years in a row NBB

Negative result in 2024 and 2025.
Tight liquidity NBB

Cash and receivables cover 53 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

BIOQUBE VENTURES from Hasselt, company number BE0738714089, closed financial year 2025 with a result of € -31,934 after tax. For that financial year BIOQUBE VENTURES recorded a gross margin of € -26,324 and equity of € 33,323. Compared with financial year 2024, the result moved from € -17,376 to € -31,934. The company made a loss. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 30, 2026.

What it is worth Healthy

€ 33,323

▼ 49% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -31,934

▼ 84 % more loss than in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 165,947

▲ € 143,477 vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € -28,177.

People and assets in 2025

Full-time equivalents

Average over the fiscal year, from the social balance sheet.

Vehicles and equipment

€ 8,540

▼ 21% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 341,848

▼ 21% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Key figures per fiscal year Download key figures (CSV)
	2021	2022	2024	2025	Change 2024 → 2025
Gross margin	€ 103,493 Gross margin 2021: € 103,493 First fiscal year in the series	€ 312,788 Gross margin 2022: € 312,788 ▲ 202% vs 2021 (€ 103,493) Favourable step	€ 28,365 Gross margin 2024: € 28,365 ▼ 91% vs 2022 (€ 312,788) Unfavourable step	€ -26,324 Gross margin 2025: € -26,324 ▼ € 54,689 vs 2024 (€ 28,365) Unfavourable step	▼ € 54,689
Profit after taxes	€ 58,026 Profit after taxes 2021: € 58,026 First fiscal year in the series	€ 179,627 Profit after taxes 2022: € 179,627 ▲ 210% vs 2021 (€ 58,026) Favourable step	€ -17,376 Profit after taxes 2024: € -17,376 ▼ € 197,003 vs 2022 (€ 179,627) Unfavourable step	€ -31,934 Profit after taxes 2025: € -31,934 ▼ € 14,559 vs 2024 (€ -17,376) Unfavourable step	▼ € 14,559
Equity	€ 146,113 Equity 2021: € 146,113 First fiscal year in the series	€ 325,740 Equity 2022: € 325,740 ▲ 123% vs 2021 (€ 146,113) Favourable step	€ 65,257 Equity 2024: € 65,257 ▼ 80% vs 2022 (€ 325,740) Unfavourable step	€ 33,323 Equity 2025: € 33,323 ▼ 49% vs 2024 (€ 65,257) Unfavourable step	▼ 49%
Total debts	€ 222,631 Total debts 2021: € 222,631 First fiscal year in the series	€ 177,056 Total debts 2022: € 177,056 ▼ 20% vs 2021 (€ 222,631) Favourable step	€ 448,473 Total debts 2024: € 448,473 ▲ 153% vs 2022 (€ 177,056) Unfavourable step	€ 347,187 Total debts 2025: € 347,187 ▼ 23% vs 2024 (€ 448,473) Favourable step	▼ 23%
Cash	€ 188,530 Cash 2021: € 188,530 First fiscal year in the series	€ 103,225 Cash 2022: € 103,225 ▼ 45% vs 2021 (€ 188,530) Unfavourable step	€ 22,470 Cash 2024: € 22,470 ▼ 78% vs 2022 (€ 103,225) Unfavourable step	€ 165,947 Cash 2025: € 165,947 ▲ € 143,477 vs 2024 (€ 22,470) Favourable step	▲ € 143,477
Retained profit	€ 84,613 Retained profit 2021: € 84,613 First fiscal year in the series	€ 264,240 Retained profit 2022: € 264,240 ▲ 212% vs 2021 (€ 84,613) Favourable step	€ 3,757 Retained profit 2024: € 3,757 ▼ 99% vs 2022 (€ 264,240) Unfavourable step	€ -28,177 Retained profit 2025: € -28,177 ▼ € 31,934 vs 2024 (€ 3,757) Unfavourable step	▼ € 31,934
Bank debt	€ 37,747 Bank debt 2021: € 37,747 First fiscal year in the series	€ 21,155 Bank debt 2022: € 21,155 ▼ 44% vs 2021 (€ 37,747) Favourable step	€ 0 Bank debt 2024: € 0 ▼ 100% vs 2022 (€ 21,155) Favourable step	€ 0 Bank debt 2025: € 0 Unchanged (€ 0) Unchanged
Balance sheet total	€ 368,744 Balance sheet total 2021: € 368,744 First fiscal year in the series	€ 502,796 Balance sheet total 2022: € 502,796 ▲ 36% vs 2021 (€ 368,744) Unchanged	€ 513,731 Balance sheet total 2024: € 513,731 ▲ 2% vs 2022 (€ 502,796) Unchanged	€ 380,510 Balance sheet total 2025: € 380,510 ▼ 26% vs 2024 (€ 513,731) Unchanged	▼ 26%
Employees (FTE)	0.2 Employees (FTE) 2021: 0.2 First fiscal year in the series	0.9 Employees (FTE) 2022: 0.9 ▲ 0.7 vs 2021 (0.2) Unchanged	0 Employees (FTE) 2024: 0 ▼ 0.9 vs 2022 (0.9) Unchanged	0 Employees (FTE) 2025: 0 Unchanged (0) Unchanged

Key figures of BIOQUBE VENTURES, fiscal years 2021 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to BIOQUBE VENTURES?

What happened at BIOQUBE VENTURES in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 30, 2026 New annual accounts for financial year 2025: loss of € 31,934. Source: NBB ↗
Apr 21, 2026 New establishment in Hasselt. KBO
Jan 1, 2020 New establishment in Hasselt. KBO
Dec 4, 2019 Start of the company according to the CBE. KBO
2019 DEBORA DUMONT MANAGEMENT COMPANY CommV became a director. NBB
2019 NICO VANDERVELPEN MANAGEMENT COMPANY BV became a director. NBB
2019 R&S Consulting BV became a director. NBB

In short

From € 58,026 profit in 2021 to € 31,934 loss in 2025.

Paid € 85,188 in corporate taxes since 2021.

Best year ever: 2022, with € 179,627 profit.

Original PDFs at the National Bank ↗

Management

R&S Consulting 33.3%

DEBORA DUMONT MANAGEMENT COMPANY 33%

NICO VANDERVELPEN MANAGEMENT COMPANY 33%

The stake of R&S Consulting, DEBORA DUMONT MANAGEMENT COMPANY, NICO VANDERVELPEN MANAGEMENT COMPANY comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

BIOQUBE VENTURES

Behind BIOQUBE VENTURES are DEBORA DUMONT MANAGEMENT COMPANY CommV, NICO VANDERVELPEN MANAGEMENT COMPANY BV and R&S Consulting BV. The shares are held by R&S Consulting (33.3%), DEBORA DUMONT MANAGEMENT COMPANY (33%) and NICO VANDERVELPEN MANAGEMENT COMPANY (33%).

Directors

According to the 2025 annual accounts

DEBORA DUMONT MANAGEMENT COMPANY CommV

Director · represented by Dumont Debora

Also active at: BQV Partners, SPICA THERAPEUTICS

since 2019

NICO VANDERVELPEN MANAGEMENT COMPANY BV

Director · represented by Nico Vandervelpen

Also active at: BQV Partners

since 2019

R&S Consulting BV

Director · represented by Dirk Reyn

Also active at: PROGRESS PHARMA

since 2019

Shareholders

R&S Consulting

33.3%

DEBORA DUMONT MANAGEMENT COMPANY

33%

NICO VANDERVELPEN MANAGEMENT COMPANY

33%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Uilstraat 30

3500 Hasselt

2.389.015.770

Thonissenlaan 51

3500 Hasselt

Active since 21 April 2026

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 4 companies are registered at this address.

All companies at this address →

ANDAZ PARTNERS

€ 7,761 gross margin · 2025

VILLA LOWIS

€ 1.5 million gross margin · 2025

BQV Partners same network

€ 448,361 gross margin · 2025

BQV

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0738.714.089
VAT number: BE 0738.714.089
Registered office: Uilstraat 30, 3500 Hasselt
Names & denominations: BIOQUBE VENTURES
Enterprise type: Rechtspersoon
Legal form: Public limited company
Legal situation: Normale toestand
Start date: 4 December 2019
Peppol: Active · Active since 25 Sept 2026
Activities · NACE: Vermogensbeheer

View on CBE Public ↗ Annual accounts (NBB) ↗

BIOQUBE VENTURES

Warning lights

Financials

What happened to BIOQUBE VENTURES?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions